Trade Summary

2 months ago, Broadwood Partners, L.P., serving as 10% owner at Insight Molecular Diagnostics Inc. (IMDX), purchased 521,739 shares at $5.75 per share, for a total transaction value of $2,999,999.00. Following this transaction, Broadwood Partners, L.P. now holds 23,863,835 shares of IMDX.

This purchase represents a 2.00% increase in Broadwood Partners, L.P.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, February 10, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 12, 2026, 2 days after the trade was made.

Insight Molecular Diagnostics Inc. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.